Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
5.86
+0.01 (0.09%)
Nov 5, 2024, 1:19 PM EST - Market open
Relay Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 951 | 1,357 | 1,806 | 3,318 | 3,733 | - | |
| Market Cap Growth | -43.34% | -24.86% | -45.57% | -11.11% | - | - | |
| Enterprise Value | 313 | 601 | 813 | 2,725 | 3,043 | - | |
| Last Close Price | 5.85 | 11.01 | 14.94 | 30.71 | 41.56 | - | |
| PE Ratio | - | -3.95 | -5.77 | -8.03 | -7.69 | - | |
| PS Ratio | 21.23 | 53.13 | 1307.87 | 1095.42 | 45.16 | - | |
| PB Ratio | 1.14 | 1.80 | 1.90 | 3.70 | 4.89 | - | |
| P/FCF Ratio | -3.06 | -4.46 | -7.57 | -42.61 | -35.75 | - | |
| P/OCF Ratio | -3.08 | -4.52 | -7.87 | -44.59 | -36.42 | - | |
| EV/Sales Ratio | 8.89 | 23.53 | 588.46 | 899.58 | 36.82 | - | |
| EV/EBITDA Ratio | -0.46 | -1.61 | -2.65 | -12.26 | -58.24 | - | |
| EV/EBIT Ratio | -0.45 | -1.58 | -2.61 | -12.05 | -54.54 | - | |
| EV/FCF Ratio | -0.59 | -1.97 | -3.41 | -34.99 | -29.14 | - | |
| Debt / Equity Ratio | 0.07 | 0.07 | 0.06 | 0.03 | 0.03 | 0.07 | |
| Debt / FCF Ratio | -0.18 | -0.18 | -0.24 | -0.29 | -0.23 | -0.33 | |
| Asset Turnover | 0.04 | 0.03 | 0.00 | 0.00 | 0.14 | - | |
| Quick Ratio | 15.28 | 24.78 | 15.76 | 39.60 | 55.80 | 29.69 | |
| Current Ratio | 15.64 | 25.44 | 16.00 | 40.14 | 56.49 | 30.08 | |
| Return on Equity (ROE) | -43.28% | -40.18% | -31.44% | -43.81% | -9.35% | -19.35% | |
| Return on Assets (ROA) | -26.91% | -24.40% | -18.44% | -15.63% | -5.85% | -12.79% | |
| Return on Capital (ROIC) | -29.19% | -26.15% | -20.15% | -16.54% | -5.96% | -13.07% | |
| Earnings Yield | -33.97% | -25.20% | -16.08% | -10.97% | -1.40% | - | |
| FCF Yield | -29.80% | -22.43% | -13.21% | -2.35% | -2.80% | - | |
| Buyback Yield / Dilution | -7.57% | -9.22% | -17.97% | -123.22% | -1135.17% | -38.84% | |
| Total Shareholder Return | -7.57% | -9.22% | -17.97% | -123.22% | -1135.17% | -38.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.